GGrantIndex
← Search

Stanford Cancer Institute

$124,999P30FY2023CANIH

Stanford University, Stanford CA

Investigators

Linked publications, trials & patents

Paper 39574895Paper 39534431Paper 39506045Paper 39378093Paper 39257774Paper 39179931Paper 39163262Paper 39132489Paper 39042439Paper 38997156Paper 38996463Paper 38987048Paper 38968138Paper 38838737Paper 38810650Paper 38746193Paper 38563850Paper 38496616Paper 38496500Paper 38408498Paper 38387457Paper 38278150Paper 38273211Paper 38262408Paper 38260330Paper 38200310Paper 38154193Paper 38096469Paper 37963187Paper 37917579Paper 37882771Paper 37812494Paper 37743567Paper 37667254Paper 37662553Paper 37534980Paper 37532139Paper 37527449Paper 37398193Paper 37244414Paper 37196642Paper 37184546Paper 37162847Paper 36999999Paper 36993756Paper 36813894Paper 36747642Paper 36734849Paper 36729432Paper 36729074Paper 36719070Paper 36717409Paper 36711732Paper 36701540Paper 36652552Paper 36640300Paper 36635501Paper 36624348Trial NCT05220254Trial NCT03733210Trial NCT03405142Trial NCT03241940Trial NCT03179449Trial NCT02855086Trial NCT02805075Trial NCT02762266Trial NCT02736578Trial NCT02735356Trial NCT02699723Trial NCT02695628Trial NCT02690948Trial NCT02683824Trial NCT02635074Trial NCT02624518Trial NCT02599194Trial NCT02581787Trial NCT02488070Trial NCT02440308Trial NCT02432118Trial NCT02429804Trial NCT02415608Trial NCT02401347Trial NCT02215928Trial NCT02210858Trial NCT02203565Trial NCT02184533Trial NCT02175745Trial NCT02166983Trial NCT02058550Trial NCT02030405Trial NCT02019069Trial NCT01977677Trial NCT01943188Trial NCT01928030Trial NCT01926990Trial NCT01908166Trial NCT01904643Trial NCT01898403Trial NCT01893892Trial NCT01868503

Abstract

Project Summary/Abstract This application is being submitted in response to the Notice of Special Interest (NOSI) identified as NOT-CA-23-044. The Stanford Cancer Institute’s (SCI) [2P30CA124435-14] mission is to leverage the broad and unique strengths of Stanford University in basic science, bioengineering, population science, biostatistics, technology development, clinical research, clinical care, and translation to (1) improve the diagnosis, treatment, and outcomes of cancer patients; (2) understand cancer etiologies among diverse populations; and (3) decrease cancer incidence in the SCI catchment area and beyond. SCI is committed to understanding and addressing the cancer burden and reducing cancer disparities in our community. This proposal is in direct response to a request from the SCI Community Advisory Board to foster research on strategies to reduce disparities in access to evidence-based cancer care services in the catchment area at the patient and community level. Cancer research discoveries over the last 30 years have stimulation critical innovations in cancer prevention and care delivery, greatly improving cancer survival. However, communities with the greatest cancer burden are often last to benefit from these innovations. Community benefit policies, including medical financial assistance and community-building initiatives, aim to incentivize hospital systems to address the needs of underserved patients and communities. Yet, the effectiveness of these policies in addressing persistent disparities in cancer care access and burden are largely unknown. Building on our prior research on community benefits, this proposal aims to engage community and health system partners in the development of more equity-focused community benefit policies to improve cancer outcomes and reduce disparities. Specifically, we seek to understand the complex and interacting factors that drive community benefit spending in order to inform equity-focused allocation decisions in the 10-county SCI catchment area. Activities proposed in this research supplement will establish a foundation for future research studies to develop and validate a simulation-based tool to inform the allocation of community benefits in ways that better address critical financial assistance needs for cancer patients and foster a more equitable allocation of community benefit resources.

View original record on NIH RePORTER →